−2.95 TWD
−561.30 M TWD
1.16 B TWD
108.41 M
About MEDIGEN BIOTECHNOLOGY CORPORATION
Sector
CEO
Shih Chung Chang
Headquarters
Taipei
Website
Founded
1999
ISIN
TW0003176004
FIGI
BBG000GJPF90
Medigen Biotechnology Corp. engages in the research and development of new drugs and vaccines, cytotherapy, advanced nucleic acid testing, generic drugs, aesthetic medicine products, and the production and sale of vaccine-related products. It operates through the following segments: Nucleic Acid Testing, New Drug and Vaccine Research and Development, Cytotheraphy, Generic Drug, Aesthetic, Medicine Product, and Dietary Supplement. The company was founded on December 31, 1999 and is headquartered in Taipei, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 3176 is 31.50 TWD — it has decreased by −0.63% in the past 24 hours. Watch MEDIGEN BIOTECHNOLOGY CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange MEDIGEN BIOTECHNOLOGY CORPORATION stocks are traded under the ticker 3176.
3176 stock has fallen by −4.83% compared to the previous week, the month change is a −9.22% fall, over the last year MEDIGEN BIOTECHNOLOGY CORPORATION has showed a −34.31% decrease.
3176 reached its all-time high on Jun 16, 2014 with the price of 486.00 TWD, and its all-time low was 4.30 TWD and was reached on Mar 27, 2006. View more price dynamics on 3176 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
3176 stock is 3.71% volatile and has beta coefficient of 0.48. Track MEDIGEN BIOTECHNOLOGY CORPORATION stock price on the chart and check out the list of the most volatile stocks — is MEDIGEN BIOTECHNOLOGY CORPORATION there?
Today MEDIGEN BIOTECHNOLOGY CORPORATION has the market capitalization of 4.39 B, it has decreased by −3.76% over the last week.
Yes, you can track MEDIGEN BIOTECHNOLOGY CORPORATION financials in yearly and quarterly reports right on TradingView.
3176 net income for the last quarter is −26.93 M TWD, while the quarter before that showed 11.95 M TWD of net income which accounts for −325.39% change. Track more MEDIGEN BIOTECHNOLOGY CORPORATION financial stats to get the full picture.
No, 3176 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIGEN BIOTECHNOLOGY CORPORATION EBITDA is −542.74 M TWD, and current EBITDA margin is −91.10%. See more stats in MEDIGEN BIOTECHNOLOGY CORPORATION financial statements.
Like other stocks, 3176 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIGEN BIOTECHNOLOGY CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIGEN BIOTECHNOLOGY CORPORATION technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIGEN BIOTECHNOLOGY CORPORATION stock shows the strong sell signal. See more of MEDIGEN BIOTECHNOLOGY CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.